This website is best viewed using the horizontal display on your tablet device.
This website is best viewed using the vertical display on your mobile device.
As a healthcare provider, you play a critical role in the ABECMA treatment process, helping RRMM patients navigate their journey with ABECMA. Get information and tools you need to help support your patients below.
From the treatment process to adverse event monitoring and management information, it’s here—so you can continue to guide your patients throughout their treatment journey.
RRMM=relapsed/refractory multiple myeloma.
Learn How ABECMA Is Made
Meet Your ABECMA Care Team
ABECMA Patient Stories — Dana
ABECMA Patient Stories — Mary
Dedicated to providing solutions-oriented support and knowledge to help patients throughout the CAR T cell therapy journey.
Bristol Myers Squibb’s Cell Therapy 360 program supports patients and caregivers throughout their treatment journey, from enrollment through the initial post-infusion monitoring period, with referral resources, patient support navigators, logistical support*, and financial support*.
*Eligibility requirements may apply.
Patients may enroll in support programs offered through Cell Therapy 360 after a certified CAR T treatment center determines that ABECMA is the right treatment for them.
The services and support programs offered through Cell Therapy 360 are available only to people who are receiving a CAR T cell therapy from Bristol Myers Squibb, such as ABECMA. Certain restrictions and eligibility requirements apply.
CAR=chimeric antigen receptor.